Hereditary interstitial kidney disease
- PMID: 20807609
- PMCID: PMC4264385
- DOI: 10.1016/j.semnephrol.2010.06.003
Hereditary interstitial kidney disease
Abstract
Autosomal-dominant interstitial kidney disease is characterized by slow progression of chronic kidney disease in patients with bland urinary sediment and no or low-grade proteinuria. There are at least three subtypes. Patients with mutations in the UMOD gene encoding uromodulin suffer from precocious gout in addition to chronic kidney failure. Diagnosis can be achieved through genetic analysis of the UMOD gene. Patients with mutations in the REN gene encoding renin suffer from anemia in childhood, hyperuricemia, mild hyperkalemia, and progressive kidney disease. Genetic analysis of the REN gene can be performed to diagnose affected individuals. There is a third form of inherited interstitial kidney disease for which the cause has not been found. These individuals suffer from chronic kidney disease with no other identified clinical signs. Linkage to chromosome 1 has been identified in a number of these families. Proper diagnosis is valuable not only to the affected individual but also to the entire family and can facilitate treatment, transplantation, and research efforts.
Copyright 2010 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.Clin J Am Soc Nephrol. 2011 Oct;6(10):2429-38. doi: 10.2215/CJN.01220211. Epub 2011 Aug 25. Clin J Am Soc Nephrol. 2011. PMID: 21868615 Free PMC article.
-
Autosomal Dominant Tubulointerstitial Kidney Disease.Adv Chronic Kidney Dis. 2017 Mar;24(2):86-93. doi: 10.1053/j.ackd.2016.11.012. Adv Chronic Kidney Dis. 2017. PMID: 28284384 Free PMC article. Review.
-
A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review.Ren Fail. 2018 Nov;40(1):146-151. doi: 10.1080/0886022X.2018.1450757. Ren Fail. 2018. PMID: 29569962 Free PMC article. Review.
-
Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.Am J Kidney Dis. 2018 Sep;72(3):411-418. doi: 10.1053/j.ajkd.2018.03.019. Epub 2018 May 18. Am J Kidney Dis. 2018. PMID: 29784615
-
Uromodulin-associated kidney disease.Nephron Clin Pract. 2011;118(1):c31-6. doi: 10.1159/000320889. Epub 2010 Nov 11. Nephron Clin Pract. 2011. PMID: 21071970 Review.
Cited by
-
Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.Pediatr Nephrol. 2022 May;37(5):933-946. doi: 10.1007/s00467-021-05118-4. Epub 2021 May 22. Pediatr Nephrol. 2022. PMID: 34021396 Free PMC article. Review.
-
Serum uromodulin and decline of kidney function in older participants of the population-based KORA F4/FF4 study.Clin Kidney J. 2020 May 1;14(1):205-211. doi: 10.1093/ckj/sfaa032. eCollection 2021 Jan. Clin Kidney J. 2020. PMID: 33564420 Free PMC article.
-
Autosomal Dominant Tubulointerstitial Kidney Disease-Uromodulin Misclassified as Focal Segmental Glomerulosclerosis or Hereditary Glomerular Disease.Kidney Int Rep. 2020 Jan 8;5(4):519-529. doi: 10.1016/j.ekir.2019.12.016. eCollection 2020 Apr. Kidney Int Rep. 2020. PMID: 32274456 Free PMC article.
-
Autosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein.Sci Rep. 2019 Aug 12;9(1):11601. doi: 10.1038/s41598-019-48014-6. Sci Rep. 2019. PMID: 31406136 Free PMC article.
-
Diagnosis and Long-term Management of Uromodulin Kidney Disease.Cureus. 2019 Mar 19;11(3):e4270. doi: 10.7759/cureus.4270. Cureus. 2019. PMID: 31157132 Free PMC article.
References
-
- Hildebrandt F, Omram H. New insights: nephronophthisis-medullary cystic kidney disease. Pediatr Nephrol. 2001;16:168–176. - PubMed
-
- Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis. 2003;42:658–676. - PubMed
-
- Hoyer JR, Sisson SP, Vernier RL. Tamm-Horsfall glycoprotein ultrastructural immunoperoxidase localization in rat kidney. Lab Invest. 1979;41:168–173. - PubMed
-
- Malagolini N, Cavallone D, Serafini-Cessi F. Intracellular transport, cell-surface exposure and release of recombinant Tamm-Horsfall glycoprotein. Kidney Int. 1997;52:1340–1350. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
